Fragile X Syndrome: A Comprehensive Review of Etiology, Pathophysiology, and Management

Shagufta Naz, A and Snigdha, Bairagi and Ramya, A (2026) Fragile X Syndrome: A Comprehensive Review of Etiology, Pathophysiology, and Management. In: Innovations in Pharmaceutical Therapeutics and Drug Delivery. SCIENTIFIC RESEARCH REPORTS, pp. 85-92. ISBN 978-81-685538-8-0

[thumbnail of Fragile X Syndrome A Comprehensive Review of.pdf] Text
Fragile X Syndrome A Comprehensive Review of.pdf - Published Version

Download (644kB)
[thumbnail of Innovations in Pharmaceutical Therapeutics and Drug Delivery.pdf] Text
Innovations in Pharmaceutical Therapeutics and Drug Delivery.pdf

Download (4MB)

Abstract

Fragile X syndrome (FXS) is the most common inherited single-gene cause of intellectual disability and a significant genetic cause of autism spectrum disorder. The disorder exhibits variable expressivity and reduced penetrance, particularly in females due to X-chromosome inactivation.

Clinically, FXS is associated with intellectual disability, behavioral problems, anxiety, and autism-related features. Diagnosis is primarily performed using molecular genetic techniques such as polymerase chain reaction (PCR) and Southern blot analysis to detect CGG repeat expansion and methylation status in the FMR1 gene. This chapter presents a comprehensive overview of the etiology, pathophysiology, diagnosis, and management of Fragile X syndrome.

Item Type: Book Section
Subjects: Pharmacy Practice > Pathophysiology
Domains: Pharmacy Practice
Depositing User: Mr IR Admin
Date Deposited: 11 May 2026 09:12
Last Modified: 11 May 2026 11:21
URI: https://ir.vistas.ac.in/id/eprint/17003

Actions (login required)

View Item
View Item